Siemens Healthcare Becomes Siemens Healthineers
On May 4th, 2016, Siemens Healthcare unveiled its new name Siemens Healthineers.
The new name embodies the company’s pioneering spirit and engineering expertise in the healthcare industry. It is unique and bold and gives a new identity to the organization and to the people – the people accompanying, serving and inspiring healthcare providers worldwide – the people behind outstanding products and solutions.
“We have an exceptional track record of engineering and scientific excellence and are consistently at the forefront of developing innovative clinical solutions that enable providers to offer efficient, high quality patient care. Going forward as Siemens Healthineers, we will leverage this expertise to provide a wider range of customized clinical solutions that support our customers business holistically. We are confident in our capability to become their inspiring partner on our customers’ journey to success”, explained Bernd Montag, CEO of Siemens Healthcare. “Our new name is a bold signal for our ambition and expresses our identity as a people company – 45,000 employees worldwide who are passionate about empowering healthcare providers to optimally serve their patients.”
There is no doubt about healthcare rapidly changing globally. Everyone in the industry works on discovering new ways to improve peoples‘ health while structures, incentives, and processes are radically changing to support the growing patient population. Strategies of consolidation, industrialization, and population health management are being developed to stand up to the rising pressure. Siemens Healthineers understands these challenges including the need for continually driving metrics around clinical, operational and financial efficiencies.
Siemens Healthineers will continue to strengthen its leading portfolio across the medical imaging and laboratory diagnostics business, and complementing it with new offerings such as management‐, consulting‐, and digital services, and further technologies in the growing therapeutic and molecular diagnostics market.